APVO
Aptevo Therapeutics·NASDAQ
--
--(--)
--
--(--)
APVO fundamentals
Aptevo Therapeutics (APVO) released its earnings on Aug 11, 2025: revenue was -- (YoY 0.00%), beat estimates; EPS was -8.4 (YoY -402.99%), beat estimates.
Revenue / YoY
--
0.00%
EPS / YoY
-8.4
-402.99%
Report date
Aug 11, 2025
EPS
Revenue
Revenue & Expenses
Key Indicators
Aptevo Therapeutics (APVO) key financial stats and ratios, covering profitability, financial health, and leverage.
Aptevo Therapeutics (APVO)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Aptevo Therapeutics (APVO)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Aptevo Therapeutics (APVO)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Aptevo Therapeutics (APVO) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Aptevo Therapeutics (APVO) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is the market's earnings forecast for Aptevo Therapeutics next quarter?Did Aptevo Therapeutics beat or miss consensus estimates last quarter?What were the key takeaways from Aptevo Therapeutics’s earnings call?What is Aptevo Therapeutics's gross profit margin?What factors drove the changes in Aptevo Therapeutics's revenue and profit?What is Aptevo Therapeutics's latest dividend and current dividend yield?What does Aptevo Therapeutics do and what are its main business segments?What were the key takeaways from Aptevo Therapeutics's earnings call?
